Kidney Cancer Symptoms
Most kidney cancers (>50%) are now detected incidentally on imaging rather than through symptoms, but when symptoms do occur, visible haematuria is the most powerful predictor, followed by flank pain, abdominal mass, and various paraneoplastic syndromes 1, 2, 3.
Classic Triad (Now Rare)
The traditional presentation of kidney cancer—flank pain, gross haematuria, and palpable abdominal mass—has become uncommon, occurring in only 2.9% of patients in contemporary series 4. This decline reflects the widespread use of abdominal imaging (ultrasound, CT) that detects tumors before they become symptomatic 1, 5, 3.
Primary Symptoms to Recognize
Urological Symptoms
- Visible (gross) haematuria: The single most powerful predictor with an odds ratio of 37 and positive predictive value of 1.0% in patients ≥60 years 6
- Non-visible haematuria (detected on dipstick)
- Flank pain (odds ratio 1.4) 6
- Recurrent urinary tract infections (odds ratio 1.8) 6
Constitutional Symptoms
- Unexplained weight loss (frequently neglected by patients) 7
- Persistent fatigue (odds ratio 1.5) 6
- Unexplained fever
- Night sweats 8
Abdominal Findings
Paraneoplastic Syndromes
Kidney cancer remains the "Internist's cancer" due to relatively frequent paraneoplastic presentations 1, 5, 1:
- Hypercalcaemia (most common metabolic abnormality)
- Erythrocytosis (elevated red blood cell count)
- Stauffer's syndrome: Cholestatic liver dysfunction without liver metastases, resolving after tumor resection
- Hypertension (from renin secretion)
- New-onset diabetes (rare but documented) 9
Laboratory Abnormalities
When kidney cancer is suspected, specific laboratory findings include 1, 5:
- Microcytosis (odds ratio 2.6)
- Raised inflammatory markers (CRP, ESR; odds ratio 2.4)
- Thrombocytosis (odds ratio 2.2)
- Low haemoglobin/anaemia (odds ratio 1.9)
- Raised creatinine (odds ratio 1.7)
- Leukocytosis (odds ratio 1.5)
- Abnormal liver function (odds ratio 1.3)
- Raised blood sugar (odds ratio 1.2)
Metastatic Presentations
Patients may present with symptoms from distant metastases 10:
- Bone pain (bone metastases)
- Persistent cough or dyspnea (lung metastases)
- Neurological symptoms (brain metastases)
- Deterioration in performance status
- Lymphadenopathy
Critical Clinical Pearls
Symptomatic patients have worse outcomes: The presence of symptoms is independently associated with higher stage disease, increased risk of metastases, more intraoperative complications, and reduced overall survival 7. However, the classic triad itself, while rare, does not necessarily predict worse survival when adjusted for stage 4.
Weight loss and flank pain are frequently dismissed by patients as unrelated to serious disease, leading to diagnostic delays 7.
Visible haematuria warrants urgent referral: When considered alongside bladder cancer risk, the overall risk of urinary tract malignancy from haematuria justifies immediate investigation 6, 11.
Asymptomatic haematuria may be the only finding in patients with non-specific symptoms like weight loss or loin pain—dipstick urinalysis is essential 8.
Temporal Trends
The proportion of symptomatic presentations has been declining over time (68.6% of patients had at least one symptom in 2004-2017, with decreasing trend; p<0.001) 4. This corresponds with increased incidental detection and earlier stage at diagnosis, contributing to improved survival rates 1, 2, 3.
Late recurrence is possible: Kidney cancer can recur decades after nephrectomy (documented cases up to 33 years later), sometimes presenting with unusual metabolic abnormalities 9.